How to buy Sunshine Biopharma stock (Sunshine Biopharma)

Sunshine Biopharma is conducting a public offering of units comprised of one share of common stock and one warrant exercisable for one share of common stock. The offering, however, is contingent upon the approval of the company's application for listing on the Nasdaq.

The company's stock currently trades on the Over-the-Counter Markets pink sheets under the ticker symbol "SBFM." If its application is approved, it will trade on the Nasdaq under the same ticker symbol.

Our top picks for where to buy Sunshine Biopharma stock

Buy Sunshine Biopharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Sunshine Biopharma stock price (NASDAQ: SBFM)

Use our graph to track the performance of SBFM stocks over time.

Sunshine Biopharma shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$3.24
52-week range	$2.11 - $608.00
50-day moving average more info button	$2.81
200-day moving average more info button	$27.75
Wall St. target price	$300.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-127.90

Is it a good time to buy Sunshine Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sunshine Biopharma price performance over time

Historical closes compared with the close of $3 from 2024-12-23

1 week (2024-12-18)	9.09%
1 month (2024-11-25)	22.95%
3 months (2024-09-25)	4.53%
6 months (2024-06-25)	577.20%

1 year (2023-12-22)	1,090.00%
2 years (2022-12-23)	-99.77%
3 years (2021-12-23)	-99.99%
5 years (2019-12-24)	-99.91%

Sunshine Biopharma financials

Revenue TTM	$33 million
Gross profit TTM	$1.7 million
Return on assets TTM	-10.75%
Return on equity TTM	-17.98%
Profit margin	-12.82%
Book value	$12.52
Market Capitalization more info button	$5.5 million

TTM: trailing 12 months

Sunshine Biopharma share dividends

We're not expecting Sunshine Biopharma to pay a dividend over the next 12 months.

You may also wish to consider:

• Sanofi ADR (SNY.US) (4.33% forward annual dividend yield)
• Pfizer (PFE.US) (6.64% forward annual dividend yield)

Have Sunshine Biopharma's shares ever split?

Sunshine Biopharma's shares were split on a 1:20 basis on 7 August 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sunshine Biopharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Sunshine Biopharma shares which in turn could have impacted Sunshine Biopharma's share price.

Sunshine Biopharma share price volatility

Over the last 12 months, Sunshine Biopharma's shares have ranged in value from as little as $2.1056 up to $608. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sunshine Biopharma's is -1.036. This would suggest that Sunshine Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Sunshine Biopharma has bucked the trend.

To put Sunshine Biopharma's beta into context you can compare it against those of similar companies.

• Sanofi ADR (SNY.US): 0.445
• Pfizer (PFE.US): 0.615
• Moderna (MRNA.US): 1.69

Sunshine Biopharma overview

Sunshine Biopharma, Inc. , a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1. 1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications.

Frequently asked questions

What percentage of Sunshine Biopharma is owned by insiders or institutions?
Currently 0.234% of Sunshine Biopharma shares are held by insiders and 1.843% by institutions. How many people work for Sunshine Biopharma?
Latest data suggests 44 work at Sunshine Biopharma. When does the fiscal year end for Sunshine Biopharma?
Sunshine Biopharma's fiscal year ends in December. Where is Sunshine Biopharma based?
Sunshine Biopharma's address is: 333 Las Olas Way, Fort Lauderdale, FL, United States, 33301 What is Sunshine Biopharma's ISIN number?
Sunshine Biopharma's international securities identification number is: US8677814035